Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Retinoblastoma, Extraocular clinical trials

1 of 1 indexed Retinoblastoma, Extraocular trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Retinoblastoma, Extraocular: 1 US clinical trial tracked, 1 recruiting.

Retinoblastoma, Extraocular is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Washington, running 1 of these trials.

Enrollment posture brief

Registry condition retinoblastoma-extraocular

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Retinoblastoma, Extraocu (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Retinoblastoma, Extraocular

Retinoblastoma, Extraocular lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Retinoblastoma, Extraocular on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Retinoblastoma, Extraocular is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Retinoblastoma, Extraocular records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Targeted Long-read sequencing Genetic
1 trials

US sites by state

Facility locations filed on Retinoblastoma, Extraocular trials. A trial with sites in several states counts in each.

Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Retinoblastoma, Extraocular page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Retinoblastoma, Extraocular condition card totals 1 registered trials; most-linked intervention Targeted Long-read sequencing; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.